The pharmaceutical sector is varied but typically involves a high concentration of value (property and profit) in a small area..

The inherent hazards associated with several of the manufacturing processes such as highly flammable liquids/gasses and clean rooms as well as the continued consolidation of manufacturing and operations has resulted in increased single site exposures. Customer dependence on key sites means that businesses must make every effort to identify and manage their exposures effectively.

Examining these exposures in isolation is not sufficient to identify the risks presented. Only through a tailored location to corporate review process can the true picture be revealed and the risks understood. elciem has the expertise and understanding of the pharmaceutical industry to be able to add value and reduce the cost of risk to many of the companies we have worked with.

elciem has been involved in many projects within this sector, some of which have included:

• Risk engineering audits for a large North American pharmaceutical organisation
• Supply chain reviews and analysis for global manufacturers